China Health Holding Announces Execution Of Definitive Acquisition Agreement For 60% Of Henan Furen Huaiqingtang Pharmaceutical Co. Ltd.

LAS VEGAS--(BUSINESS WIRE)--Aug. 25, 2006--Julianna Lu, President/CEO of China Health Holding, Inc. (OTCBB:CHHH), a developer, marketer and manufacturer of natural herbal supplement products based on traditional Chinese medicine, announced today that CHHH has executed a definitive acquisition agreement with Henan Furen Huaiqingtang Pharmaceutical Co. Ltd. and Henan Furen Pharmaceuticals Group Co. Ltd. and the shareholders of Henan Furen Huaiqingtang Pharmaceutical Co. Ltd. for the acquisition 60% of the outstanding stock of Henan Furen Huaiqingtang Pharmaceuticals Co. Ltd. (HFHP).

MORE ON THIS TOPIC